Antares Pharma Inc

NASDAQ:ATRS   3:59:52 PM EDT
4.38
-0.07 (-1.57%)
Products

Antares Pharma Announces FDA Acceptance Of IND Application For ATRS-1902

Published: 07/22/2021 12:53 GMT
Antares Pharma Inc (ATRS) - Antares Pharma Announces FDA Acceptance of Ind Application for Atrs-1902 for Adrenal Crisis Rescue.
Antares Pharma Inc - Ind Application for Atrs-1902 is Expected to Initiate in 2h 2021.